2022 Case Studies
Ever since the WHO updates on the TB screening guidelines, the global effort to scale up and implement portable digital X-ray systems and CAD has been tremendous. The inclusion of Delft Light & CAD4TB in the Diagnostics Catalogue of the StopTB Partnership’s Global Drug Facility and Wambo/PFSCM has furthered the accessibility and deployment of these new tools worldwide.
We support our partners with cutting-edge solutions, like ultra-portable X-ray systems and CAD4TB, to perform rapid and accurate screening for TB.
Delve into our 2022 case studies. These studies showcase the progress and impactful outcomes from a year of dedicated research and collaboration.
Nigeria – TB Case-finding among school children
A study in Lagos comparing TB screening methods among schoolchildren found that mobile X-ray screening with CAD was more effective than the WHO four-symptom screen, detecting more TB cases with fewer tests needed. This [...]
Nigeria – TB Screening among Inmates with Delft Light & CAD4TB
The deployment of the Delft Light Backpack Portable Digital X-ray and CAD4TB in Nigerian prisons under a USAID project led to the screening of 4,920 inmates, identifying 72 TB cases. This initiative underscores the [...]
Tajikistan – Active Case Finding in Remote Areas with Delft Light & CAD4TB
Tajikistan's introduction of Delft Light and CAD4TB in 2022 has significantly enhanced TB screening in remote and mountainous areas, leading to the identification and treatment initiation of numerous TB cases among key and vulnerable [...]
Uganda – Community level screening with OneStopTB Clinic
Targeted TB screening in high-risk areas, using X-rays and confirmatory tests, reached over 11,000 people, diagnosing 249 TB cases with a majority starting treatment promptly. This strategy highlights the effectiveness of mobile clinics in [...]
Uganda – TB screening among PLHIV with Delft Light & CAD4TB
In Uganda, TB screening using digital X-rays and CAD among people living with HIV led to significant TB detection, especially within the HIV-positive population. This approach underscores the importance of prioritizing such screenings for [...]